Home › Cancro del polmone non a piccole cellule › Iowa

Studi clinici su Cancro del polmone non a piccole cellule nello stato di Iowa

29 studi su Cancro del polmone non a piccole cellule cercano partecipanti presso sedi nello stato di Iowa.

Città nello stato di Iowa

Testo ufficiale dello studio (inglese)

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Mary Greeley Medical Center, Ames
McFarland Clinic - Ames, Ames
UI Health Care Mission Cancer and Blood - Ankeny Clinic, Ankeny
e altri 14

In reclutamentoFase 3

Età 18 e oltre · Tutti i sessi · Aggiornato il 2 ott 2026 · NCT04267848

Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial

Mary Greeley Medical Center, Ames
McFarland Clinic - Ames, Ames
Physicians' Clinic of Iowa PC, Cedar Rapids
e altri 4

In reclutamentoFase 3

Età 18 e oltre · Tutti i sessi · Aggiornato il 1 ott 2026 · NCT07388524

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

Mary Greeley Medical Center, Ames
McFarland Clinic - Ames, Ames
UI Health Care Mission Cancer and Blood - Ankeny Clinic, Ankeny
e altri 11

In reclutamentoFase 3

Età 18 e oltre · Tutti i sessi · Aggiornato il 1 ott 2026 · NCT06498635

Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)

University of Iowa Health Care Cancer Services Quad Cities, Bettendorf
University of Iowa Hospitals & Clinics, Iowa City
University of Iowa Health Care, Mission Cancer + Blood, Waukee

In reclutamentoFase 3

Età 18 e oltre · Tutti i sessi · Aggiornato il 29 set 2026 · NCT06881784

A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

Accellacare of McFarland, Ames

In reclutamentoFase 2

Età 18 e oltre · Tutti i sessi · Aggiornato il 25 set 2026 · NCT06667076

A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung Cancer

Research Site, Des Moines
Research Site, Waterloo

In reclutamentoFase 3

Età 18 e oltre · Tutti i sessi · Aggiornato il 25 set 2026 · NCT06868277

A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors

Local Institution - 0065, Iowa City

In reclutamentoFase 1/2

Età 18 e oltre · Tutti i sessi · Aggiornato il 23 set 2026 · NCT06618287

Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer

Physicians Clinic of Iowa, Cedar Rapids
Holden Comprehensive Cancer Center, University of Iowa Hospitals and Clinics, Iowa City

In reclutamentoFase 2/3

Età 18 e oltre · Tutti i sessi · Aggiornato il 22 set 2026 · NCT06712316

A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)

Mercy Medical Center, Cedar Rapids

In reclutamentoFase 3

Età 18 e oltre · Tutti i sessi · Aggiornato il 22 set 2026 · NCT06875310

Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors

University of Iowa Hospital and Clinics, Iowa City

In reclutamentoFase 1

Età 18 e oltre · Tutti i sessi · Aggiornato il 21 set 2026 · NCT05983432

A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)

Research Site, Waterloo

In reclutamentoFase 3

Età 18 e oltre · Tutti i sessi · Aggiornato il 18 set 2026 · NCT06692738

Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1

Clinical Study Site, Waukee

In reclutamentoFase 3

Età 18 e oltre · Tutti i sessi · Aggiornato il 18 set 2026 · NCT06767514

A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors

University of Iowa, Iowa City

In reclutamentoFase 1

Età 18 e oltre · Tutti i sessi · Aggiornato il 17 set 2026 · NCT07020117

A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer

Mission Cancer + Blood - IMMC, Des Moines
University of Iowa, Iowa City

In reclutamentoFase 3

Età 18 e oltre · Tutti i sessi · Aggiornato il 8 set 2026 · NCT06793215

A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung Cancer

University of Iowa Hospitals & Clinics PARENT, Iowa City

In reclutamentoFase 1/2

Età 18 e oltre · Tutti i sessi · Aggiornato il 26 ago 2026 · NCT06892548

A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors

University of Iowa, Iowa City

In reclutamentoFase 1/2

Età 18 e oltre · Tutti i sessi · Aggiornato il 17 ago 2026 · NCT04895709

A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors

University of Iowa, Iowa City

In reclutamentoFase 1

Età 18 e oltre · Tutti i sessi · Aggiornato il 22 lug 2026 · NCT05208762

Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer

UI Health Care Mission Cancer and Blood - Ankeny Clinic, Ankeny
Mercy Hospital, Cedar Rapids
Oncology Associates at Mercy Medical Center, Cedar Rapids
e altri 7

In reclutamentoFase 3

Età 18 e oltre · Tutti i sessi · Aggiornato il 14 lug 2026 · NCT06686771

Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors

University of Iowa Health Care, Iowa City

In reclutamentoFase 1

Età 18 e oltre · Tutti i sessi · Aggiornato il 11 giu 2026 · NCT05283330

KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors

University of Iowa Hospitals & Clinics, Iowa City

In reclutamentoFase 1

Età 18 e oltre · Tutti i sessi · Aggiornato il 8 giu 2026 · NCT06026410

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

UI Health Care Mission Cancer and Blood - Ankeny Clinic, Ankeny
UI Health Care Mission Cancer and Blood - West Des Moines Clinic, Clive
Iowa Methodist Medical Center, Des Moines
e altri 4

In reclutamentoFase 2

Età 18 e oltre · Tutti i sessi · Aggiornato il 3 giu 2026 · NCT05642572

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)

Mary Greeley Medical Center, Ames
McFarland Clinic - Ames, Ames
McFarland Clinic - Trinity Cancer Center, Fort Dodge
e altri 1

In reclutamentoFase 2

Età 18 e oltre · Tutti i sessi · Aggiornato il 6 mag 2026 · NCT06116682

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

Mary Greeley Medical Center, Ames
McFarland Clinic - Ames, Ames
UI Health Care Mission Cancer and Blood - Ankeny Clinic, Ankeny
e altri 7

In reclutamentoFase 2

18 Minutes · Tutti i sessi · Aggiornato il 5 mag 2026 · NCT06031688

Adjuvant Pembrolizumab vs Observation Following Curative Resection for Stage I Non-small Cell Lung Cancer (NSCLC) With Primary Tumors Between 1-4 cm

University of Iowa Hospitals and Clinics, Iowa City

In reclutamentoFase 2

Età 18 e oltre · Tutti i sessi · Aggiornato il 5 mag 2026 · NCT04317534

A Study to Evaluate the Efficacy and Safety of Sutetinib Maleate Capsule in Locally Advanced or Metastatic NSCLC

Mission Cancer + Blood - Mission Cancer Foundation, Des Moines

In reclutamentoFase 2

Età 18 e oltre · Tutti i sessi · Aggiornato il 24 apr 2026 · NCT06010329

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

UI Health Care Mission Cancer and Blood - Ankeny Clinic, Ankeny
University of Iowa Healthcare Cancer Services Quad Cities, Bettendorf
Physicians' Clinic of Iowa PC, Cedar Rapids
e altri 10

In reclutamentoStudio osservazionale

Età 18 e oltre · Tutti i sessi · Aggiornato il 17 mar 2026 · NCT06418204

GEMINI-NSCLC: NSCLC Biomarker Study

University of Iowa, Iowa City

In reclutamentoStudio osservazionale

Età 18 e oltre · Tutti i sessi · Aggiornato il 5 feb 2026 · NCT05236114

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Massive Bio SYNERGY-AI site, Iowa City

In reclutamentoStudio osservazionale

Tutte le età · Tutti i sessi · Aggiornato il 28 ott 2025 · NCT03452774

Test-retest Evaluation of [18F]F-AraG PET

University of Iowa Hospitals and Clinics, Iowa City

In reclutamentoFase 2

Età 18 e oltre · Tutti i sessi · Aggiornato il 24 ott 2024 · NCT06084806

Fonte: ClinicalTrials.gov, dati recuperati il 5 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.